New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
06:22 EDTINCYIncyte price target raised to $75 from $44 at Jefferies
Jefferies raised its price target for Incyte shares to $75 from $44 on expectations the company's IDO inhibitor with ipilimumab for melanoma could "unlock huge value." The firm says it heard positive commentary from four investigators involved in the Phase 2 study and keeps a Buy rating on the stock.
News For INCY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
07:33 EDTINCYBrean Capital to hold a summit
Subscribe for More Information
November 20, 2014
08:25 EDTINCYIncyte management to meet with UBS
Subscribe for More Information
November 17, 2014
11:06 EDTINCYLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
November 13, 2014
13:32 EDTINCYLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
13:29 EDTINCYLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
13:26 EDTINCYLeerink biotech analysts hold an analyst/industry conference call
Biotech Analysts provide a preview of items being discussed at the upcoming 56th Annual Meeting of ASH including Leukemia/MDS on an Analyst/Industry conference call to be held on November 20 at 10 am.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use